News
Tenpoint eyes presbyopia drug launch after FDA nod
Tenpoint is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis, and LENZ with a dual-acting rival.
Saturday 13 June 2026
